Johns Hopkins Breached Keytruda Deal, Merck Sharp Says

By Gina Kim · November 29, 2022, 8:01 PM EST

Merck Sharp took Johns Hopkins University to federal court in Maryland on Tuesday over claims that the university secretly obtained patents for inventions based on a collaborative clinical study treating cancer patients...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Merck Sharp & Dohme LLC v. The Johns Hopkins University

Case Number

Court

Maryland

Nature of Suit

Patent

Date Filed

November 29, 2022

Recent Articles By Gina

June 10, 2025
Amazon Can't Duck Suit Over Non-FDA Approved Supplements
May 29, 2025
Split 9th Circ. Says Spa's Rule On Certain Trans Women Biased
May 20, 2025
Medical Organizations Sue Feds For Removing Health Data
May 13, 2025
Planned Parenthood Wants Teen Program Fund Rule Blocked
April 28, 2025
Baker Donelson Picks Up Longtime HHS OIG Atty In Maryland
April 17, 2025
Incyte Can Get Novartis' Privileged Info On Drug Royalty Deal
April 17, 2025
9th Circ. Revives Defect Suit Against CR Bard Over Clot Filter
April 03, 2025
Amazon, Biotech Net $1.9M Win Against Fake Supplement Sellers
March 26, 2025
Healthcare Providers To Pay $63M Over False Spinal Diagnoses
March 26, 2025
Drugmaker Execs Hid Approval Process Roadblocks, Suit Says